Global Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market, By Technology (PCR, Immunodiagnostics, Clinical Microbiology, INAAT, DNA Sequencing and NGS, DNA Microarrays, Others), Disease Type (COVID-19, HIV, HAIs, Hepatitis, CT/NG, HPV, TB, Influenza, Other), End User (Diagnostic Laboratories, Hospitals and Clinics, Academic Research Institutes, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market
Over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 2,331.14 million by 2028 and will grow at a CAGR of 12.23% in the above mentioned forecast period. The rise in the prevalence of infectious diseases and onset of COVID-19 is amongst the important factor expected to intensify the growth and demand of over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market.
Over the Counter (OTC) and Direct to Consumer (DTC) has highly changed the clinical lab testing industry. Infectious diseases are amongst the leading causes of morbidity and mortality across the world. Diagnostics is the main step for the disease discovery and treatment leading to suppression of infectious diseases.
The rise in the focus on R&D and funding in infectious disease diagnostics and rise in the awareness for early disease diagnosis in developing countries are also expected contributes to the growth in the global market over the forecast period of 2021 to 2028. Also the rise in the technological advancements in infectious disease diagnostics and rapid advancements in over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics techniques are also likely to enhance the growth of the market. Furthermore, the rapid shift in focus from centralized laboratories to decentralized POC testing are also amongst the significant factors expected to fuel the growth of the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market.
The rapid increase in the inclination of end-user towards point-of-care testing, rapid technological advancements and increase in the number of R&D are anticipated to offer significant growth opportunities for the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market in the forecast period of 2021 to 2028.
However, the unfavorable reimbursement scenario and changing regulatory landscape are expected to curb the growth of the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market, whereas the operational barriers can challenge the growth of the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market.
This over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market Scope and Market Size
Over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is segmented on the basis of technology, disease type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
The technology segment of the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is segmented into PCR, immunodiagnostics, clinical microbiology, INAAT, DNA sequencing and NGS, DNA microarrays and others.
- Based on disease type, the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is segmented into COVID-19, HIV, HAIs, hepatitis, CT/NG, HPV, TB, influenza and others,
- On the basis of end user, the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, academic research institutes and others.
Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market Country Level Analysis
Over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market is analyzed and market size insights and trends are provided by country, technology, disease type and end user as referenced above.
The countries covered in the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market owing to the well developed healthcare system in the US and Canada and strong presence of many leading national clinical laboratories.
The country section of the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market Share Analysis
Over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market.
The major players covered in the over the counter (OTC)/direct to consumer (DTC) infectious disease diagnostics market report are Abbott, Bio-Rad Laboratories Inc., BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Inc., Siemens AG, F. Hoffmann-La Roche AG, Hologic, Inc., Qiagen, Cardinal Health, Quest Diagnostics Incorporated, Ador Diagnostics, Akonni Biosystems, Inc., Alveo Technologies, Binx Health Inc., bioMérieux, Inc., Curetis, Sysmex Europe GmbH and Diasorin S.p.A., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-